TB Alliance Names Sandeep Juneja as Senior Vice President for Market Access
NEW YORK (June 4, 2018) – TB Alliance today announced the appointment of Sandeep Juneja to Senior Vice President for […]
News
News
Global MPs Urge Heads of State to Act on Tuberculosis
NEW YORK (April 26, 2018) – In a statement released on Thursday, members of the Global TB Caucus, a group
After World TB Day, High Expectations for Action
Dear friends, The world came together this past Saturday to mark World TB Day. It was a truly impressive display
Nancy Miller-Rich Joins TB Alliance Board of Directors
NEW YORK (March 6, 2018)—TB Alliance, a not-for-profit organization dedicated to finding faster-acting and affordable drug regimens to fight tuberculosis
ZeNix Clinical Trial Announced
NEW YORK (7 February, 2018) — TB Alliance has announced the start of a clinical trial of a three-drug regimen
Ending TB Means Investing in R&D
This week, as health ministers, diplomats and other representatives meet to discuss tuberculosis (TB) at the World Health Organization (WHO)
Ariel Pablos-Méndez Joins TB Alliance Board of Directors
NEW YORK (November 6, 2017)—TB Alliance today announced the appointment of Dr. Ariel Pablos-Méndez to its board of directors. As
TB Alliance Statement on WHO’s Global Tuberculosis Report 2017
The World Health Organization’s (WHO) 2017 Global Tuberculosis Report, released today, showed a reduction in TB deaths in 2016 compared
TB Alliance Moves Two Novel Tuberculosis Drugs into Human Trials
GUADALAJARA (10 October, 2017) — TBA-7371 and sutezolid entered phase 1 clinical trials, TB Alliance announced today. Both compounds have
TB Alliance Endorses WHO Designation of TB as a “Global Priority Pathogen”
NEW YORK (27 September, 2017)—TB Alliance commends the World Health Organization (WHO) for recognizing tuberculosis (TB) as a priority pathogen